Xoft Inc.: 12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting

Published: Apr 28, 2010

LAS VEGAS, April 28 /PRNewswire/ -- Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBx™, System to deliver intraoperative radiation therapy (IORT) is growing as clinical experience demonstrates the isotope-free cancer treatment platform is a patient and physician friendly alternative. Xoft will showcase a variety of IORT oncology applications at the 11th Annual Meeting of the American Society of Breast Surgeons here, April 28-May 2, 2010.

Back to news